| Identification | Back Directory | [Name]
RAD51-IN-2 | [CAS]
2301085-04-9 | [Synonyms]
RAD51-IN-2
RAD-51-IN-2,RAD51 IN 2,RAD51IN2
Carbamic acid, N-[3-[[(1,1-dimethylethyl)amino]sulfonyl]-4-[2-[trans-4-[[(1-methylethoxy)carbonyl]amino]cyclohexyl]-5-thiazolyl]phenyl]-, 1-methylethyl ester | [Molecular Formula]
C27H40N4O6S2 | [MDL Number]
MFCD34469435 | [MOL File]
2301085-04-9.mol | [Molecular Weight]
580.76 |
| Chemical Properties | Back Directory | [density ]
1.27±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 100 mg/mL (172.19 mM; Need ultrasonic) | [form ]
Solid | [pka]
11.70±0.50(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Emzadirib (RAD51-IN-2) is a RAD51 inhibitor extracted from patent WO2019/051465A1[1]. | [storage]
Store at -20°C | [References]
[1] Alfredo C. Castro, et al. Rad51 inhibitors. WO2019/051465A1. |
|
|